Global Prevalence of Child Myopia Is Increasing

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 25, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Sept. 25, 2024 -- The global prevalence of child myopia is increasing and is projected to reach 39.80 percent in 2050, according to a systematic review and meta-analysis published online Sept. 24 in the British Journal of Ophthalmology.

Jinghong Liang, from Sun Yat-Sen University in Guangzhou, China, and colleagues conducted a literature review to examine the global and regional prevalence of myopia and its occurrence within specific demographic groups. The analysis included 276 studies, with 5,410,945 children or adolescents from 50 countries in six continents.

The researchers observed a gradual increase in the pooled prevalence of myopia, varying from 24.32 to 35.81 percent from 1990 to 2023; prevalence is projected to reach 36.59 and 39.80 percent in 2040 and 2050, respectively. A higher proportion of myopia prevalence is exhibited in individuals residing in East Asia (35.22 percent) or in urban areas (28.55 percent) and in females, adolescents, and high school students (33.57, 47.00, and 45.71 percent, respectively).

"It is crucial to recognize that myopia may become a global health burden in the future," the authors write. "To address this growing epidemic, further research with a more region-specific approach is required to develop effective strategies at the local level."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords